RT Journal Article
SR Electronic
T1 376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A425
OP A425
DO 10.1136/jitc-2023-SITC2023.0376
VO 11
IS Suppl 1
A1 Nayar, Ribhu
A1 Khokhar, Shazad A
A1 Jangalwe, Sonal
A1 Padmanabhan, Sveta
A1 Nabilsi, Nancy
A1 Parsons, Teagan
A1 Coleman, Jeffrey
A1 Hsiung, Adam
A1 Chang, Chunghun
A1 Tsai, Henry
A1 Arain, Shehla
A1 Lozac’hmeur, Ariane
A1 Nguyen, Andrew
A1 Rathbun, Jessica
A1 Yang, Qidi
A1 Pham, Ruey
A1 Harris, Sam
A1 Soni, Shardul
A1 Danek, Tyler
A1 Marshall, Katie
A1 Jensen, Amanda
A1 Riley, Chris
A1 Dukaj, Livio
A1 Cristofaro, Alexander
A1 Wang, Yun
A1 Buonomo, Erica
A1 Gurer, Cagan
A1 Boudot, Antoine J
A1 Chattopadhyay, Shrikanta
A1 Barton, Debora
A1 MacBeath, Gavin
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A425.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.